Stockreport

IsomAb appoints Dr Philip Brainin as Chief Executive Officer [Yahoo! Finance]

ASTELLAS PHARMA UNSP/ADR  (ALPMY) 
NASDAQ:AMEX Investor Relations: astellas.com/jp/en/investors
PDF Strong preclinical data demonstrates ISM-001's novel disease-modifying mechanism to re-establish healthy angiogenesis Chronic Stable Angina is a major undertreated co [Read more]